NCT07043764 Caring Contacts Via Text Message for Suicidal Adolescents After Emergency Department Discharge
| NCT ID | NCT07043764 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ann & Robert H Lurie Children's Hospital of Chicago |
| Condition | Suicide Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2026-09-15 |
| Primary Completion | 2028-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2026-09-15 with a primary completion date of 2028-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot clinical trial is to learn if Caring Contacts (brief, hopeful, supportive text messages) can be delivered to adolescents with suicidal thoughts or behaviors after discharge from the emergency department, and to understand if adolescents find it acceptable to receive Caring Contacts. Researchers will also begin to explore how suicidal thoughts and behaviors change over time among participants who receive Caring Contacts along with treatment as usual, compared to participants who only receive treatment as usual. All participants will be invited to answer survey questions when they first enroll in the study and 1, 3, 6, and 12 months after their emergency department visit. Some participants will receive Caring Contacts (brief, hopeful, supportive text messages) after their emergency department visit. Some participants will be invited to complete an interview about their experiences receiving Caring Contacts.
Eligibility Criteria
Inclusion Criteria: * 12 to \<18 years of age * Present to the emergency department with suicidal thoughts or behaviors as indicated by the Ask Suicide-Screening Questions (ASQ) * Have a cell phone that can receive text messages * Proficient in English * Anticipated disposition of discharge from the emergency department Exclusion Criteria: * In care of the Department of Children and Family Services * Unable to participate meaningfully in assent, assessments, or the intervention, as determined by the treating clinician, including any of the following: acute or chronic cognitive impairment, acute psychosis, current severe agitation, current alcohol or drug intoxication
Contact & Investigator
Jennifer A. Hoffmann, MD, MS
PRINCIPAL INVESTIGATOR
Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University
Frequently Asked Questions
Who can join the NCT07043764 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Suicide Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07043764 currently recruiting?
Yes, NCT07043764 is actively recruiting participants. Contact the research team at jhoffmann@luriechildrens.org for enrollment information.
Where is the NCT07043764 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT07043764 clinical trial?
NCT07043764 is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. The principal investigator is Jennifer A. Hoffmann, MD, MS at Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University. The trial plans to enroll 56 participants.